Abstract
Autoimmune hepatitis (AIH) is a chronic hepatitis of unknown etiology characterized by continuing hepatocellular necrosis and inflammation that afflicts 100,000 to 200,000 persons in the United States. It is a rare manifestation of systemic sclerosis. Only about nine reports of this association have been previously reported in the literature. Importantly, all cases had the limited clinical form of systemic. The authors describe herein the first report of a patient with diffuse systemic sclerosis who was diagnosed with AIH with positive antimitochondrial antibody and had an excellent response to immunosuppressive drugs. We also briefly review the literature regarding this issue.
References
Abu-Shakra M, Guillemin F, Lee P (1994) Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 24:29–39
Marie I, Levesque H, Tranvouez JL, François A, Riachi G, Cailleux N, Courtois H (2001) Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) 40:102–106
McFarlane IG (1998) The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42:599–602
Khalifa M, Ben Jazia E, Hachfi W, Sriha B, Bahri F, Letaief A (2006) Autoimmune hepatitis and morphea: a rare association. Gastroenterol Clin Biol 30:917–918
West M, Jasin HE, Medhekar S (2006) The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. Semin Arthritis Rheum 35:344–348
Narbutt J, Lesiak A, Kwiecień A, Sysa-Jedrzejowska A, Kuydowicz J (2005) Scleroderma-like lesions in the course of autoimmune hepatitis. Przegl Lek 62:314–316
Lis-Swiety A, Brzezinska-Wcislo L, Pierzchala E, Wcislo-Dziadecka D (2006) Systemic sclerosis–polymyositis overlap syndrome accompanied by autoimmune hepatitis and sarcoidosis of mediastinal lymph nodes. J Eur Acad Dermatol Venereol 20:107–108
Ngo Mandag N, Van Gossum M, Rickaert F, Golstein M (2007) Autoimmune hepatitis and CREST syndrome. Rev Med Brux 28:528–531
Ishikawa M, Okada J, Shibuya A, Kondo H (1995) CRST syndrome (calcinosis cutis, Raynaud’s phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis. Intern Med 34:6–9
Yabe H, Noma K, Tada N, Mochizuki S, Nagano M (1992) A case of CREST syndrome with rapidly progressive liver damage. Intern Med 31:69–73
Montano-Loza AJ, Carpenter HA, Czaja AJ (2008) Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 42:1047–1053
D’Angelo WA, Fries JF, Masi AT, Schulman LE (1969) Pathologic observations in systemic sclerosis(scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428–440
White B (2001) Systemic sclerosis, epidemiology, pathology and pathogenesis. In Primer on the rheumatic diseases. 2nd ed, Canada, Arthritis Foundation, 353–356
Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
JF Carvalho received a grant from Federico Foundation.
Rights and permissions
About this article
Cite this article
Rodrigues, C.E.M., Borges, C.L. & de Carvalho, J.F. Diffuse systemic sclerosis and autoimmune hepatitis: a unique association. Clin Rheumatol 29, 799–801 (2010). https://doi.org/10.1007/s10067-010-1390-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1390-x